Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded latency-associated nuclear antigen (LANA), which interacts with cellular proteins, plays a central role in modification of viral and/or cellular gene expression. Here, we show that LANA associates with glucocorticoid receptor (GR), and that LANA enhances the transcriptional activity of GR.
Introduction
Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8, is a human gamma herpes virus that mainly infects endothelial cells and B-lymphocytes [1, 2, 3] . Numerous proteins encoded by the KSHV open reading frame during latency and lytic cycles of the virus have been identified, of which some are believed to transform the infected cells [1, 4] . Although KSHV was originally isolated from Kaposi's sarcoma (KS), the virus is also related to primary effusion lymphoma and multicentric Castleman disease [5, 6] . Latency-associated nuclear antigen (LANA), a KSHV protein, is critical for the persistence of KSHV episomes, and functions in this capacity by tethering viral episomes to chromosomes during mitosis [7, 8, 9] . In addition, LANA interacts physically with various cellular proteins that regulate transcriptional activities, resulting in interfering with critical regulators of the cell cycle and enhancing anti-apoptotic effects [10, 11, 12, 13] .
Glucocorticoid receptor (GR) is a member of the nuclear hormone receptor superfamily localized in the cytoplasm. Inactive GR is bound to a large protein complex including Hsp90 [14, 15] . When glucocorticoid (GC) binds to GR, Hsp90 dissociates, and the GC/GR complex translocates into the nucleus where it binds to specific palindromic sequences termed glucocorticoid response elements (GREs) [14, 15] . GC treatment of cells results in an increase or decrease in the transcription of a variety of target genes [16, 17] .
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were grown in RPMI 1640 medium containing 10% FBS. DG75 cells were nucleofected using Human B Cell Nucleofector Kit (Amaxa biosystems, Cologne, Germany) as described previously [13] . The stimulated cells were harvested and assayed for the luciferase activity using the Dual-Luciferase Reporter Assay System (Promega, Madison, WI) according to the manufacturer's instructions.
Immunoprecipitation, immunoblotting and DNA binding assay, Immunoprecipitation
and Western blotting were performed as previously described [13] . The cells were harvested and lysed in lysis buffer (50 mM Tris-HCl, pH 7.4, 0.15 M NaCl, 1% NP-40, 1 mM sodium orthovanadate, 1 mM phenylmethylsulfonyl fluoride, and 10 mg /ml each of aprotinin, pepstatin, and leupeptin). The immunoprecipitates from cell lysates were resolved on SDS-PAGE and transferred to an Immobilon filter (Millipore; Bedford, MA), which was then immunoblotted with antibodies. To measure GR DNA binding, cell extracts were treated with the immobilized GRE consensus oligonucleotide-Sepharose conjugate (Santa Cruz) as described previously [32] .
Indirect Immunofluorescence microscopy, HeLa cells (5x10 4 ) seeded on a glass plate
were fixed with 4 % paraformaldehyde and reacted with respective antibodies. The cells were then reacted with FITC-conjugated anti-rabbit IgG or rhodamine-conjugated anti-mouse IgG (Chemicon) and observed under a confocal laser fluorescent microscope [31] . Images were obtained by using a Zeiss LSM 510 laser scanning microscope with an Apochromat x63/1.4 oil immersion objective and x4 zoom. Nuclei were counterstained with 4', 6-diamidino-2-phenylindole (DAPI) (Wako, Osaka, Japan).
Cell viability assay, The numbers of viable DG75 cells after the indicated treatments
were measured using a WST-8 Statistical analysis, The significance of differences between group means was determined by Student's t-test.
Results

LANA augments transcriptional activation of GR in 293T and HeLa cells
To assess the functional relevance between LANA and GR, we tested whether LANA affects GR-mediated transcriptional activation by transient transfection of 293T cells. 293T cells were transfected with GR and MMTV-LUC or GRE-LUC with or without LANA, and then luciferase activities were determined after treatment with dexamethasone (DEX). When 293T cells were co-transfected GR and LANA, transcriptional activation of MMTV-LUC and GRE-LUC was augmented in a dose-dependent manner ( Fig. 1A and B ). We also tested the effects of LANA on endogenous GR activation in HeLa cells. HeLa cells were transfected with GRE-LUC with or without LANA, and then luciferase activities were determined after treatment with DEX. The same results were obtained because the transcriptional activation of GRE-LUC was augmented in a LANA dose-dependent manner ( Fig. 1C ). To confirm whether the DEX-induced GRE-LUC activation was mediated by endogenous GR, the cells were treated with RU486, a GR antagonist, under the same conditions. As a result, the GRE-LUC activity was completely blocked by RU486 after DEX stimulation in the presence or absence of LANA (Fig. 1C ). Therefore, LANA specifically enhances GR transcriptional activities. 9
GR and LANA physically interact in vivo
A mechanism consistent with the above data may be a DIRECT interaction between GR and LANA. To examine this possibility, we performed co-immunoprecipitation experiments in 293T cells that were transiently transfected with Myc-GR and FLAG-LANA expression vectors. The transfected 293T cells were lysed and subjected to immunoprecipitation with an anti-FLAG antibody. The immunoprecipitates were then analyzed by western blotting with an anti-Myc antibody. As shown in Fig 
LANA influences the nuclear retention and DNA binding activity of GR
To further characterize the interaction between GR and LANA, we determined the cellular location of the interaction. Ectopically expressed LANA localized to the nucleus in the presence or absence of DEX stimulation, while DEX stimulation induced translocation of endogenous GR into the nuclei of HeLa cells (Fig. 4A ). In the absence of DEX stimulation, LANA expression tended to slightly enhance nuclear localization of GR. After DEX stimulation, we observed a significantly higher rate of cells with nuclear localization of GR in LANA-expressing HeLa cells than in control cells ( Fig. 4A and B) . The strong co-localization of LANA and GR suggests that activated GR interacts with LANA in the nucleus. Finally, we examined whether LANA expression affects the DNA-binding capacity of GR. A pull-down assay with consensus CRE oligonucleotides revealed that activated GR bound to the GRE sequence more efficiently in the presence of LANA (Fig. 4C) . Therefore, LANA appears to enhance GR activities via augmentation of its DNA-binding activity through a DIRECT protein-protein interaction.
Discussion
In this study, we demonstrated a novel interaction between GR and KSHV-derived LANA.
LANA augmented the transcriptional activity of GR in cells. Furthermore, overexpression of LANA enhanced GR activity and GR-mediated growth suppression of human B-lymphocytes. As a possible mechanism, our results suggest that LANA-mediated enhancement of DEX-induced GR activation occurs via a physical interaction between LANA and GR in the nucleus.
LANA is a 222-232-kDa nuclear protein expressed from open reading frame 73 of the KSHV genome [4, 7, 8, 9] . LANA contains several conserved sequences including acidic-, proline-, and glutamine-rich domains as well as a zinc finger DNA-binding domain, leucine zipper, and potential nuclear localization signal. Its domain structure suggests that LANA plays a pivotal role in KSHV-infected cells. Indeed, LANA tethers the viral genome to the host cell genome, thus it is involved in long-term maintenance of viral episomal DNA in dividing cells [7, 8, 9] . In addition, LANA interacts with a variety of cellular proteins in the host. LANA can directly bind to and inhibit tumor suppressor p53 [10] . Through direct binding to glycogen synthase kinase 3β and extracellular signal-regulated kinase (ERK), LANA enhances activation of ERK and c-myc. LANA also associates with hypophosphorylated retinoblastoma protein, and transactivates E2F-mediated promoter activities [11] . Our previous report also showed that LANA acts as a transcriptional activator for STAT3 [13] . In the present study, we identified GR as a new binding partner of LANA.
The C-terminal portion of LANA (932-1162 aa) recognized the GR protein, and this region contains the DNA-binding domain of the LANA protein. After DEX stimulation, GRE-LUC activity was significantly enhanced and DG75 cell viability was decreased by LANA binding to GR. Some reports indicate that the incidence of KS is clinically increased by GCs [20] [21] [22] [23] [24] [25] [26] [27] . The involvement of GR-mediated signals in KSHV-related malignancies will clarify the significance of LANA/GR interactions. It is also noteworthy that a recent study has indicated the LANA-nuclear RNA interaction through both N-and C-termini of LANA domain [33] . Similarly, the cellular non-coding RNA, growth arrest-specific transcript 5
(GAS5) has been demonstrated to interact GR directly via the DNA-binding domain of GR and represses GR activity by acting as a decoy GRE [34] . Therefore, these non-coding
RNAs may bridge the LANA association with GR. Further detailed analysis will be required on this issue.
KSHV has a biphasic life cycle consisting of a life-long latent phase and a transient lytic reactivation phase [1, 35] . Only limited regions are activated in KSHV during latent infection. In contrast, the full repertoire of viral genes is activated in a temporally regulated manner during the lytic phase [1, 4] . Two major KSHV products, LANA and RTA (replication and transcription activator), are believed to interact with each other, leading to switching between latent and lytic phases [36] . RTA acts as an initiator and regulator of KSHV lytic DNA replication, and LANA represses RTA gene expression. Importantly, this inhibitory effect of LANA is partly regulated by its post-translational modification including arginine methylation, phosphorylation, and sumoylation [4, 37, 38] . KSHV reactivation is also induced by certain stimuli such as viral co-infection as well as hypo-and hyper-oxidative responses [1, 4] . Several reports indicate the involvement of GCs in KSHV reactivation [20] [21] [22] [23] [24] [25] [26] [27] . GC treatment induces lytic viral gene expression in some, but not all, KSHV-infected B-lymphocyte lines. Therefore, LANA/GR interactions appear to enhance transition from latent to lytic phases during GC treatment.
In acquired immunodeficiency syndrome-related KS, highly active antiretroviral therapy is associated with a decrease in the size and number of lesions, leading to extension of the 14 time to treatment failure [39, 40] . For patients with advanced KS, liposomal anthracyclines and taxane paclitaxel are clinically available. Although standard therapies are effective in the short-term, KS recurrence is common. Therefore, new therapeutic approaches are required. Recently, drugs have been developed to target LANA-mediated, angiogenetic, or anti-apoptotic signals. Our results may support the therapeutic potential of such LANA-targeting strategies. 
Figure Legends
